Hasil Pencarian - Ganesh Raghu

Perbaiki Hasil
  1. 1
    Pharmacotherapy for idiopathic pulmonary fibrosis: current landscape and future potential

    Pharmacotherapy for idiopathic pulmonary fibrosis: current landscape and future potential oleh Ganesh Raghu

    Diterbitkan 2017-09-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    Interstitial lung disease (ILD) in India: Insights and lessons from the prospective, landmark ILD-India registry

    Interstitial lung disease (ILD) in India: Insights and lessons from the prospective, landmark ILD-India registry oleh Ganesh Raghu, Sanjeev Mehta

    Diterbitkan 2016-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    Antineutrophil cytoplasmic antibody-associated interstitial lung disease: a review

    Antineutrophil cytoplasmic antibody-associated interstitial lung disease: a review oleh Suha Kadura, Ganesh Raghu

    Diterbitkan 2021-11-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  4. 4
    Antifibrotic therapy for fibrotic lung disease beyond idiopathic pulmonary fibrosis

    Antifibrotic therapy for fibrotic lung disease beyond idiopathic pulmonary fibrosis oleh Bridget F. Collins, Ganesh Raghu

    Diterbitkan 2019-10-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  5. 5
    Cryptogenic organising pneumonia: current understanding of an enigmatic lung disease

    Cryptogenic organising pneumonia: current understanding of an enigmatic lung disease oleh Ganesh Raghu, Keith C. Meyer

    Diterbitkan 2021-08-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  6. 6
    Lung transplantation for interstitial lung disease

    Lung transplantation for interstitial lung disease oleh Siddhartha G. Kapnadak, Ganesh Raghu

    Diterbitkan 2021-08-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  7. 7
    Rheumatoid arthritis-associated lung disease

    Rheumatoid arthritis-associated lung disease oleh Megan Shaw, Bridget F. Collins, Lawrence A. Ho, Ganesh Raghu

    Diterbitkan 2015-03-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  8. 8
    Fibrotic interstitial lung diseases and air pollution: a systematic literature review

    Fibrotic interstitial lung diseases and air pollution: a systematic literature review oleh Sergio Harari, Ganesh Raghu, Antonella Caminati, Mario Cruciani, Massimo Franchini, Piermannuccio Mannucci

    Diterbitkan 2020-08-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  9. 9
    Scleroderma lung disease

    Scleroderma lung disease oleh Joshua J. Solomon, Amy L. Olson, Aryeh Fischer, Todd Bull, Kevin K. Brown, Ganesh Raghu

    Diterbitkan 2013-03-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  10. 10
    Anti-acid therapy in idiopathic pulmonary fibrosis: insights from the INPULSIS® trials

    Anti-acid therapy in idiopathic pulmonary fibrosis: insights from the INPULSIS® trials oleh Ulrich Costabel, Jürgen Behr, Bruno Crestani, Wibke Stansen, Rozsa Schlenker-Herceg, Susanne Stowasser, Ganesh Raghu

    Diterbitkan 2018-09-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  11. 11
    Efficacy and safety of nintedanib in patients with advanced idiopathic pulmonary fibrosis

    Efficacy and safety of nintedanib in patients with advanced idiopathic pulmonary fibrosis oleh Luca Richeldi, Martin Kolb, Stéphane Jouneau, Wim A. Wuyts, Birgit Schinzel, Susanne Stowasser, Manuel Quaresma, Ganesh Raghu

    Diterbitkan 2020-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  12. 12
    Clinical experience with antifibrotics in fibrotic hypersensitivity pneumonitis: a 3-year real-life observational study

    Clinical experience with antifibrotics in fibrotic hypersensitivity pneumonitis: a 3-year real-life observational study oleh Vasilios Tzilas, Argyris Tzouvelekis, Evangelos Bouros, Theodoros Karampitsakos, Maria Ntassiou, Eleni Avdoula, Athena Trachalaki, Katerina Antoniou, Ganesh Raghu, Demosthenes Bouros

    Diterbitkan 2020-11-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  13. 13
    Combination of esomeprazole and pirfenidone enhances antifibrotic efficacy in vitro and in a mouse model of TGFβ-induced lung fibrosis

    Combination of esomeprazole and pirfenidone enhances antifibrotic efficacy in vitro and in a mouse model of TGFβ-induced lung fibrosis oleh Afshin Ebrahimpour, Manisha Ahir, Min Wang, Anil G. Jegga, Mark D. Bonnen, N. Tony Eissa, Sydney B. Montesi, Ganesh Raghu, Yohannes T. Ghebre

    Diterbitkan 2022-11-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  14. 14
    Regional distribution of high-attenuation areas on chest computed tomography in the Multi-Ethnic Study of Atherosclerosis

    Regional distribution of high-attenuation areas on chest computed tomography in the Multi-Ethnic Study of Atherosclerosis oleh Bina Choi, Steven M. Kawut, Ganesh Raghu, Eric Hoffman, Russell Tracy, Purnema Madahar, Elana J. Bernstein, R. Graham Barr, David J. Lederer, Anna Podolanczuk

    Diterbitkan 2020-03-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  15. 15
    Identification of usual interstitial pneumonia pattern using RNA-Seq and machine learning: challenges and solutions

    Identification of usual interstitial pneumonia pattern using RNA-Seq and machine learning: challenges and solutions oleh Yoonha Choi, Tiffany Ting Liu, Daniel G. Pankratz, Thomas V. Colby, Neil M. Barth, David A. Lynch, P. Sean Walsh, Ganesh Raghu, Giulia C. Kennedy, Jing Huang

    Diterbitkan 2018-05-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  16. 16
    Esomeprazole attenuates inflammatory and fibrotic response in lung cells through the MAPK/Nrf2/HO1 pathway

    Esomeprazole attenuates inflammatory and fibrotic response in lung cells through the MAPK/Nrf2/HO1 pathway oleh Afshin Ebrahimpour, Min Wang, Li Li, Anil G. Jegga, Mark D. Bonnen, N. Tony Eissa, Ganesh Raghu, Soma Jyothula, Farrah Kheradmand, Nicola A. Hanania, Ivan O. Rosas, Yohannes T. Ghebre

    Diterbitkan 2021-05-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  17. 17
    Design and rationale for the prospective treatment efficacy in IPF using genotype for NAC selection (PRECISIONS) clinical trial

    Design and rationale for the prospective treatment efficacy in IPF using genotype for NAC selection (PRECISIONS) clinical trial oleh Anna J. Podolanczuk, John S. Kim, Christopher B. Cooper, Joseph A. Lasky, Susan Murray, Justin M. Oldham, Ganesh Raghu, Kevin R. Flaherty, Cathie Spino, Imre Noth, Fernando J. Martinez, for the PRECISIONS Study Team

    Diterbitkan 2022-12-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  18. 18
    Telomere lengths, pulmonary fibrosis and telomerase (TERT) mutations.

    Telomere lengths, pulmonary fibrosis and telomerase (TERT) mutations. oleh Alberto Diaz de Leon, Jennifer T Cronkhite, Anna-Luise A Katzenstein, J David Godwin, Ganesh Raghu, Craig S Glazer, Randall L Rosenblatt, Carlos E Girod, Edward R Garrity, Chao Xing, Christine Kim Garcia

    Diterbitkan 2010-05-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  19. 19
    Improved Prediction of PET Inflammation in Cardiac Sarcoidosis with Radiomics Texture Features on Cardiac Magnetic Resonance Using Least Absolute Shrinkage and Selection Operator Analysis

    Improved Prediction of PET Inflammation in Cardiac Sarcoidosis with Radiomics Texture Features on Cardiac Magnetic Resonance Using Least Absolute Shrinkage and Selection Operator A... oleh Avanti Gulhane, MD, FSCMR, Anna Naumova, PhD, Peter Muzi, BSc, Murat Sadic, MD, PhD, Mohamed Abdemotleb, Matthew Nyflot, PhD, Ganesh Raghu, MD, Hubert Vesselle, MD, Karen Ordovas, MD, FSCMR

    Diterbitkan 2024-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  20. 20
    Long-term evaluation of the safety and efficacy of recombinant human pentraxin-2 (rhPTX-2) in patients with idiopathic pulmonary fibrosis (IPF): an open-label extension study

    Long-term evaluation of the safety and efficacy of recombinant human pentraxin-2 (rhPTX-2) in patients with idiopathic pulmonary fibrosis (IPF): an open-label extension study oleh Ganesh Raghu, Mark J. Hamblin, A. Whitney Brown, Jeffrey A. Golden, Lawrence A. Ho, Marlies S. Wijsenbeek, Martina Vasakova, Alberto Pesci, Danielle E. Antin-Ozerkis, Keith C. Meyer, Michael Kreuter, Tracy Burgess, Nikhil Kamath, Francis Donaldson, Luca Richeldi

    Diterbitkan 2022-05-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: